On-Chip Droplet Assembly for Synthetic Microbial Community Screening

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing technologies face challenges in accurately predicting interspecies interactions and environmental dependencies in microbial communities, limiting the rational engineering of beneficial consortia due to the logistical complexity and combinatorial complexity of microbial interactions.

Innovation Solution

A microfluidic screening platform that enables the parallel screening of distinct microbial and chemical compound combinations encapsulated in droplets, allowing for the construction and testing of synthetic communities at a scale of ~100,000 to ~108 communities per day, with minimal liquid handling and efficient identification of synergistic interactions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If empirical screening is used to combinatorially construct and assay synthetic communities, then comprehensive sampling of microbial combinations can be achieved, but the process becomes logistically complex and difficult to achieve on a timescale commensurate with microbial growth

Engineering Contradiction:
Improvecomprehensive sampling of microbial combinationsVSAvoidlogistical complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system segments the combinatorial screening process into discrete droplet units, where each droplet contains a specific combination of microbes. This segmentation allows parallel processing of thousands of combinations simultaneously, transforming a logistically complex sequential process into a manageable parallel system. The droplet-based compartmentalization enables independent assessment of each microbial combination without cross-contamination.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces microfluidic devices as an intermediary platform between microbial culture and high-throughput screening. This intermediary system automates droplet generation, combination formation, and assay execution, eliminating the need for manual liquid handling and reducing logistical complexity. The microfluidic intermediary handles the combinatorial construction automatically, enabling comprehensive sampling at scale.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If the number of discrete input microbial types is increased to improve community complexity assessment, then the combinatorial complexity of interactions increases exponentially, but this makes screening increasingly difficult and time-consuming

Engineering Contradiction:
Improvemicrobial community complexity assessmentVSAvoidscreening time
Core Design Contradiction:
Adaptability or versatilityVSLoss of time

Solution Approach 1:

The system performs preliminary action by pre-generating droplets containing individual microbial types before the combinatorial mixing step. Each droplet is pre-labeled or pre-characterized, so that when combinations are formed, the system can immediately assess interactions without time-consuming identification steps. This preliminary preparation enables rapid screening of exponential combinations.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The microfluidic system creates copies of microbial cultures in discrete droplet formats, allowing parallel replication of experimental conditions across thousands of combinations. Instead of physically manipulating large volumes for each combination, the system uses droplet copying to distribute and assess microbial interactions simultaneously, dramatically reducing screening time while maintaining assessment versatility.

Inventive Principle:
Principle #26Copying

3Productivity

If high throughput screening is implemented to assess microbial interactions rapidly, then the number of combinations that can be tested increases, but the liquid handling complexity and resource requirements increase proportionally

Engineering Contradiction:
Improvenumber of combinations testedVSAvoidliquid handling complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent replaces manual mechanical liquid handling with automated microfluidic systems. Instead of using pipettes, syringes, or other mechanical liquid handling tools that become increasingly complex at high throughput, the system uses integrated microfluidic channels and droplet manipulation techniques. This substitution maintains high productivity while reducing the mechanical complexity and resource requirements of the liquid handling system.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Facilitates the rapid and scalable assessment of microbial community attributes, enabling comprehensive sampling of microbial combinations and identifying preferred attributes in a cost-effective manner.

Implementation Method 1

individual droplets in user-selected adjacent microwells are merged into a single merged assay, optionally by electrocoalescence, thermal coalescence or acoustic coalescence

Methodology Applied
Scientific EffectDroplet merging:

Implementation Method 2

the fluorescence of one or more agents such as Alexa Fluor 488, Alexa Fluor 555, Alexa Fluor 594 and/or Alexa Fluor 647 is measured

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Implementation Method 3

the optical screening includes measurement of luminescence and/or fluorescence

Methodology Applied
Scientific EffectLuminescence: Luminescence

Data Source

PatentUS20250376656A1Massively parallel on-chip construction of synthetic microbial communities
Publication Date: 2025.12.11 THE BROAD INST INC
  • US20250376656A1 patent drawing
  • US20250376656A1 patent drawing
  • US20250376656A1 patent drawing

AI summary

The present disclosure relates to compositions and methods for combinatorial assessment of nanoscale droplets, as specifically exemplified by massively parallel assessment of spatially-directed (while agnostic as to precise droplet content) combinations of droplets harboring distinct and independently identifiable microbial types and/or chemical compounds or mixtures. More particularly, the disclosure relates to a platform and methodologies for identifying advantageous (including synergistic, additive, etc.) microbial interactions and/or chemical compound or mixture interactions with microbes in a manner that allows for binary, trinary, etc. combinatorial assessments to be performed across a range of many discrete input types of microbes (e.g., 6-16 or more discrete input microbial types), to an extent capable of approaching comprehensive sampling and measurement of microbial community combinations from a selected panel of microbial inputs, optionally also in the presence of chemical compounds or mixtures (e.g., test compounds or mixtures for antimicrobial effect).